Proxima Therapeutics said that research presented at the annual meetings of the American Brachytherapy Society in Barcelona, Spain, found its MammoSite radiation therapy system to be more efficient than electron radiotherapy in delivering a radiation boost to a breast tumor site following whole-breast external-beam radiation.
In the study, researchers found that the median amount of targeted tissue receiving the prescribed radiation dose was 37.6% for patients who received electron-boost radiotherapy, according to the Alpharetta, GA-based vendor. With MammoSite, the coverage increased to 100%. Also, patients who were treated with MammoSite had a significantly smaller amount of healthy tissue exposed to unnecessary radiation.
By AuntMinnie.com staff writersMay 17, 2004
Related Reading
Proxima receives clearance for new MammoSite catheters, April 1, 2004
MammoSite RTS treats first Canadian patient, September 17, 2003
Proxima is cleared for MammoSite RTS, May 7, 2002
Copyright © 2004 AuntMinnie.com
